Cargando…
Evidence that S6K1, but not 4E-BP1, mediates skeletal muscle pathology associated with loss of A-type lamins
The mechanistic target of rapamycin (mTOR) signaling pathway plays a central role in aging and a number of different disease states. Rapamycin, which suppresses activity of the mTOR complex 1 (mTORC1), shows preclinical (and sometimes clinical) efficacy in a number of disease models. Among these are...
Autores principales: | Liao, Chen-Yu, Anderson, Sydney S, Chicoine, Nicole H, Mayfield, Jarrott R, Garrett, Brittany J, Kwok, Charlotte S, Academia, Emmeline C, Hsu, Yueh-Mei, Miller, Delana M, Bair, Amanda M, Wilson, Joy A, Tannady, Gabriella, Stewart, Erin M, Adamson, Stuart S, Wang, Junying, Withers, Dominic J, Kennedy, Brian K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931234/ https://www.ncbi.nlm.nih.gov/pubmed/29736257 http://dx.doi.org/10.1038/celldisc.2017.39 |
Ejemplares similares
-
Lamin B1 sequesters 53BP1 to control its recruitment to DNA damage
por: Etourneaud, Laure, et al.
Publicado: (2021) -
A Review of PI3K Inhibitors in B-Cell Malignancies
por: Cannon, Laura, et al.
Publicado: (2019) -
Longitudinal Functional Study of Murine Aging: A Resource for Future Study Designs
por: Evans, Daniel S, et al.
Publicado: (2021) -
Lamin A/C-dependent interaction with 53BP1 promotes cellular responses to DNA damage
por: Gibbs-Seymour, Ian, et al.
Publicado: (2015) -
Consequences of Lamin B1 and Lamin B Receptor Downregulation in Senescence
por: Lukášová, Emilie, et al.
Publicado: (2018)